SCHEMBL31494392

SCHEMBL31494392

FC(F)(F)c1ccnc(SCc2nc(-c3ccc4c(c3)OCO4)no2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CLK1 P49759 2/20 0.46
▸ CLK2 P49760 2/20 0.46
▸ DYRK1A Q13627 2/20 0.46
▸ CLK4 Q9HAZ1 2/20 0.46
▸ DYRK1B Q9Y463 2/20 0.46
▸ RAB9A P51151 5/20 0.45
▸ NPC1 O15118 4/20 0.45
▸ CHRM2 P08172 1/20 0.44
▸ CHRM5 P08912 1/20 0.44
▸ CHRM1 P11229 1/20 0.44
▸ MAPK1 P28482 2/20 0.43
▸ LMNA P02545 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MAPT P10636 5/20 0.42
▸ TSHR P16473 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31494404 0.86 MAPT (0.44) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL31494432 0.84 GAA (0.53) CLK4RAB9ANPC1MAPK1LMNA
SCHEMBL31494445 0.84 CHRM2 (0.44) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL27218796 0.82 MAPT (0.45) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL31494431 0.82 RAB9A (0.45) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL31494450 0.80 MAPT (0.47) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL31494419 0.78 NPC1 (0.46) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL27218642 0.77 RAB9A (0.47) RAB9ANPC1CHRM2CHRM5CHRM1
SCHEMBL31494452 0.76 MAPK1 (0.45) CLK4RAB9ANPC1CHRM2CHRM5
SCHEMBL31494388 0.76 MAPT (0.54) RAB9ANPC1MAPK1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232448-B1 AGONISTS OF FREE FATTY ACID RECEPTOR 1 AND THEIR USE IN DISEASES ASSOCIATED WITH SAID RECEPTOR Halo Therapeutics Ltd (GB) 2025-05-07 — — EP disclosed
EP-3956323-B1 OXAZOLE AND OXADIAZOLE DERIVATIVES USEFUL AS AGONISTS OF FREE FATTY ACID RECEPTOR 1 Halo Therapeutics Ltd (GB) 2025-03-05 — — EP disclosed
Send feedback